Intra-individual Comparison of Conventional and Digital PET/CT Scanners

Not Applicable

Completed

• Conditions: Breast Cancer; Esophageal Cancer; Miscellaneous Neoplasm; Lung Cancer
• Interventions: Diagnostic Test: Digital PET/CT scan

• Registration Number: NCT03457506
• Lead Sponsor: Isala

Brief Summary

In this study, the investigators will analyze the impact of digital PET/CT on the final diagnostic conclusion of the scan in patients with lung cancer, breast cancer, esophageal cancer and a group of mescellaneous cancers.

Detailed Description

There will be a single injection of the PET radiopharmaceutical FDG, followed by a conventional PET/CT scan and a digital PET scan, in this order or vice versa.

Study Timeline

• Study First Submitted: 2017-12-05
• Study Start: 2018-01-08
• Study First Submitted QC: 2018-02-28
• Study First Posted: 2018-03-07
• Status Verified: 2019-09
• Primary Completion: 2019-09-13
• Study Completion: 2019-09-13
• Last Update Submitted: 2019-09-18
• Last Update Posted: 2019-09-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 225

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Patients undergo a digital PET/CT	Digital PET/CT scan	Single arm prospective study of paired PET scans. Patients who are referred to the nuclear medicine department to undergo a PET scan, will undergo a PET/CT scan on the conventional scanner as well as the digital PET/CT scanner.

Primary Outcome Measures

Name	Time	Method
Diagnostic outcome of the PET/CT study	approximately 2 hours

Secondary Outcome Measures

Name	Time	Method
PET image quality	approximately 2 hours

Trial Locations

Locations (1)

Isala; 🇳🇱 Zwolle, Overijssel, Netherlands